AFDN and liver disorder: Collectively, our findings identify AF6 as a novel regulator of hepatocyte necroptosis, emphasizing the critical role of AF6 in sensitizing fatty liver deposits to TNFα-induced necroptosis, suggesting that AF6 may serve as therapeutic target for the prevention of necroptosis-related hepatic disease.